Mace drives growth in data centres, life sciences, and public sector
Mace, the global programme and project delivery consultant and construction expert, has made two internal senior leadership appointments within its Construct Engine to drive growth in two of its global markets, with Rob Lemming and Alister Grey becoming Managing Director for Public Sector & Life Sciences and Managing Director for Technology and Manufacturing, respectively.
These appointments are in sectors that are amongst the organisation’s fastest growing and form an integral part of the construction and consultancy business’ ambitious growth plans.
Since joining Mace in 2014, Rob Lemming has helped deliver particularly complex projects, most notably AstraZeneca’s flagship Discovery Centre in Cambridge. He has also helped to enlarge Mace’s presence in the UK life sciences and pharmaceutical market, growing the business’s pipeline in this expanding market, which is benefiting from investment brought about by the world’s growing and ageing population.
In his new role Rob, hopes to build on these foundations, firmly establishing Mace as the leading contractor in both the life sciences and public sectors and at the same time help clients respond to the demands of climate change and achieve their net zero goals in pursuit of a more sustainable world.
Alister Grey has over 30 years of experience in the industry, joining Mace in 2016. Since then, he has helped develop Mace’s Construction Management delivery model – the largest outcome of which was the successful delivery of the £1.8bn Battersea Power Station Phase 2 in London.
He subsequently became the Commercial Director for the Technology & Manufacturing Business Unit, where he oversaw some of Construct’s largest data centre projects with international blue chip technology companies. As Managing Director, he will continue to concentrate on delivery within the UK, Irish and European data centre markets, as well as supporting Mace Consult’s services in semi-conductors and gigafactories across the globe.
Gareth Lewis, Chief Executive Officer, Construction, Mace said:
“For over 30 years Mace has been delivering some of the world’s most challenging construction projects – amongst the most iconic structures ever built – but we don’t stand still.
“We have ambitious targets to expand our business across the globe and in diverse sectors, and to do this it is important that we have the right people in place.
“The appointments of Alister and Rob represent how Mace is tapping into developing markets and the depth of talent we have in our own teams to deliver our plans for growth.”
Alister Grey, Managing Director, Technology & Manufacturing, Mace Construct, says:
“There is a technology revolution underway with the rise of AI and the world needs the digital infrastructure to support it. With specialist teams of experts, working closely with our clients and supply chain, we have led the way on the delivery of challenging projects like the construction of hyperscale data centres.
“We are already delivering some of the most complex projects in the market and I look forward to playing a vital role in its resilience, safety and security.”
Rob Lemming, Managing Director, Public Sector and Life Sciences, Mace Construct, comments:
“Global pharmaceutical companies are driving wide-scale capital investment programmes to create new, cutting-edge life science facilities enabling ground-breaking research that societies will rely on for decades to come.
“I look forward to growing Mace’s presence in both of these critical sectors as social infrastructure benefits from this investment”.
These appointments are in sectors that are amongst the organisation’s fastest growing and form an integral part of the construction and consultancy business’ ambitious growth plans.
Since joining Mace in 2014, Rob Lemming has helped deliver particularly complex projects, most notably AstraZeneca’s flagship Discovery Centre in Cambridge. He has also helped to enlarge Mace’s presence in the UK life sciences and pharmaceutical market, growing the business’s pipeline in this expanding market, which is benefiting from investment brought about by the world’s growing and ageing population.
In his new role Rob, hopes to build on these foundations, firmly establishing Mace as the leading contractor in both the life sciences and public sectors and at the same time help clients respond to the demands of climate change and achieve their net zero goals in pursuit of a more sustainable world.
Alister Grey has over 30 years of experience in the industry, joining Mace in 2016. Since then, he has helped develop Mace’s Construction Management delivery model – the largest outcome of which was the successful delivery of the £1.8bn Battersea Power Station Phase 2 in London.
He subsequently became the Commercial Director for the Technology & Manufacturing Business Unit, where he oversaw some of Construct’s largest data centre projects with international blue chip technology companies. As Managing Director, he will continue to concentrate on delivery within the UK, Irish and European data centre markets, as well as supporting Mace Consult’s services in semi-conductors and gigafactories across the globe.
Gareth Lewis, Chief Executive Officer, Construction, Mace said:
“For over 30 years Mace has been delivering some of the world’s most challenging construction projects – amongst the most iconic structures ever built – but we don’t stand still.
“We have ambitious targets to expand our business across the globe and in diverse sectors, and to do this it is important that we have the right people in place.
“The appointments of Alister and Rob represent how Mace is tapping into developing markets and the depth of talent we have in our own teams to deliver our plans for growth.”
Alister Grey, Managing Director, Technology & Manufacturing, Mace Construct, says:
“There is a technology revolution underway with the rise of AI and the world needs the digital infrastructure to support it. With specialist teams of experts, working closely with our clients and supply chain, we have led the way on the delivery of challenging projects like the construction of hyperscale data centres.
“We are already delivering some of the most complex projects in the market and I look forward to playing a vital role in its resilience, safety and security.”
Rob Lemming, Managing Director, Public Sector and Life Sciences, Mace Construct, comments:
“Global pharmaceutical companies are driving wide-scale capital investment programmes to create new, cutting-edge life science facilities enabling ground-breaking research that societies will rely on for decades to come.
“I look forward to growing Mace’s presence in both of these critical sectors as social infrastructure benefits from this investment”.
Contact us
-
Mace Media Line
+44 20 3824 3600Email
